Munafa Stock Market Course + Intraday & FNO calls 
Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Intellia Therapeutics (NTLA)
Technical Analysis Report for NASDAQ stock NTLA Intellia Therapeutics. Dated: 14 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology In Vitro In Vivo Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock NTLA Intellia Therapeutics then click here. or read Experts views on Intellia Therapeutics or Forecast & share price targets of Intellia Therapeutics
Intellia Therapeutics Opened at 11.75 and Closed at: 11.88, which is 1.18% of previous session's close. It moved within a range of 11.60 and 12.11
The session was a Bullish session with an average volume of 1643902, which is -65.06% of previous session's volumes.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 2 days back on short term averages
A Golden cross was found 7 days back on mid term averages
Support for tomorrow is 11.74 and resistance for tomorrow is 12.25
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 11.62, 11.35 resistance for tomorrow's hourly charts is 12.13, 12.37
10 Day SMA for Intellia Therapeutics (NTLA) is 12.41 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Intellia Therapeutics (NTLA) is 12.58 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Intellia Therapeutics (NTLA) is 12.29 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 13.18 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Intellia Therapeutics is 12.68 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Intellia Therapeutics is at 12.58 and 200 DMA is at 12.68, while 50 DMA and 100 DMA are at 12.29 and 13.18 respectively
Intellia Therapeutics (NTLA) moving average of 20 SMA is at 12.58 and 20 EMA is at 12.36
| Date | Closing Price | 20 SMA | 20 EMA |
| 14 Mon Sep | 11.88 | 12.58 | 12.36 |
| 11 Fri Sep | 11.74 | 12.58 | 12.41 |
| 10 Thu Sep | 11.93 | 12.59 | 12.48 |
| 09 Wed Sep | 12.21 | 12.59 | 12.54 |
| 08 Tue Sep | 12.74 | 12.59 | 12.58 |
| 04 Fri Sep | 12.74 | 12.55 | 12.56 |
Intellia Therapeutics (NTLA) moving average of 50 SMA is at 12.29 and 50 EMA is at 12.58
| Date | Closing Price | 50 SMA | 50 EMA |
| 14 Mon Sep | 11.88 | 12.29 | 12.58 |
| 11 Fri Sep | 11.74 | 12.41 | 12.61 |
| 10 Thu Sep | 11.93 | 12.52 | 12.65 |
| 09 Wed Sep | 12.21 | 12.63 | 12.68 |
| 08 Tue Sep | 12.74 | 12.73 | 12.7 |
| 04 Fri Sep | 12.74 | 12.8 | 12.7 |
Intellia Therapeutics (NTLA) moving average of 100 SMA is at 13.18 and 100 EMA is at 12.89
| Date | Closing Price | 100 SMA | 100 EMA |
| 14 Mon Sep | 11.88 | 13.18 | 12.89 |
| 11 Fri Sep | 11.74 | 13.22 | 12.91 |
| 10 Thu Sep | 11.93 | 13.27 | 12.93 |
| 09 Wed Sep | 12.21 | 13.3 | 12.95 |
| 08 Tue Sep | 12.74 | 13.33 | 12.96 |
| 04 Fri Sep | 12.74 | 13.36 | 12.96 |
Intellia Therapeutics (NTLA) moving average of 200 SMA is at 12.68 and 200 EMA is at 12.69
| Date | Closing Price | 200 SMA | 200 EMA |
| 14 Mon Sep | 11.88 | 12.68 | 12.69 |
| 11 Fri Sep | 11.74 | 12.66 | 12.7 |
| 10 Thu Sep | 11.93 | 12.64 | 12.71 |
| 09 Wed Sep | 12.21 | 12.63 | 12.72 |
| 08 Tue Sep | 12.74 | 12.61 | 12.73 |
| 04 Fri Sep | 12.74 | 12.58 | 12.73 |
Intellia Therapeutics has performed better than Zai Lab in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Xeris Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Vanda Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Veru Inc in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Sol Gel in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Ptc Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!
Pacira Pharmaceuticals has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Pacira Pharmaceuticals, about 7.94% more returns!
Intellia Therapeutics has performed better than Pavmed Inc in short term. Holding Intellia Therapeutics could be a better choice for now!
National Research has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in National Research, about 4.22% more returns!
Intellia Therapeutics has performed better than Kiniksa Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Ionis Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!
Innoviva Inc has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Innoviva Inc, about 1.45% more returns!
Evolus Inc has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Evolus Inc, about 3.8% more returns!
Intellia Therapeutics has performed better than Cellectis S in short term. Holding Intellia Therapeutics could be a better choice for now!
Capricor Therapeutics has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Capricor Therapeutics, about 19.52% more returns!
Intellia Therapeutics has performed better than Benitec Biopharma in short term. Holding Intellia Therapeutics could be a better choice for now!
Biomarin Pharmaceutical has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Biomarin Pharmaceutical, about 1.39% more returns!
Axsome Therapeutics has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 1.88% more returns!
Intellia Therapeutics Technical analysis of indicators
Price action analysis of Intellia Therapeutics (NTLA) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Intellia Therapeutics in short term and the sell signal is strong.
Intellia Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Intellia Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Intellia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 12.4 and Intellia Therapeutics NTLA stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Intellia Therapeutics NTLA stock. Volume based technical analysis of Intellia Therapeutics NTLA stock is negative.
Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock NTLA Intellia Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And NTLA Experts View which covers a lot of information including buying and selling signals
NTLA future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Intellia Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
